Palo Verde Hematology Oncology — Glendale, Arizona

Palo Verde Hematology Oncology is a clinical research site located in Glendale, Arizona, United States 85304.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Palo Verde Hematology Oncology has participated in 14 clinical trials with 5 currently active.

Therapeutic areas: Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung, Metastatic Castration-Resistant Prostate Cancer.

Sponsors: Pfizer, Celgene, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palo Verde Hematology Oncology?

Palo Verde Hematology Oncology has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palo Verde Hematology Oncology conducted?

Palo Verde Hematology Oncology has 14 clinical trials on record, with 5 currently active. Their work covers Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung, Metastatic Castration-Resistant Prostate Cancer.

Is Palo Verde Hematology Oncology accredited by Crixeo Health?

Yes — Palo Verde Hematology Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Palo Verde Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.